Michael Ackermann

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Ackermann:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Director Common Stock 1.21M $24.2M $20.00 15 Jun 2022 Direct
Tarsus Pharmaceuticals, Inc. Director Common Stock 100K $2M $20.00 15 Jun 2022 By the Ackermann & Elmen-Gruys Trust Dated June 24, 2014
Tarsus Pharmaceuticals, Inc. Director Restricted Stock Units 12K $196K $16.31 16 Jun 2022 Direct
Tarsus Pharmaceuticals, Inc. Director Stock Option (right to buy) 7K $76.9K $10.99 16 Jun 2022 Direct

Insider Reports Filed by Michael Ackermann

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARS Tarsus Pharmaceuticals, Inc. 16 Jun 2022 2 $0 4 Director 01 Jul 2022, 12:31
TARS Tarsus Pharmaceuticals, Inc. 15 Jun 2022 2 $0 4 Director 17 Jun 2022, 16:51
TARS Tarsus Pharmaceuticals, Inc. 05 May 2022 1 $1.35M 4 Director 09 May 2022, 16:42
TARS Tarsus Pharmaceuticals, Inc. 01 Dec 2021 4 -$144K 4 Director 03 Dec 2021, 17:56
TARS Tarsus Pharmaceuticals, Inc. 01 Nov 2021 2 -$162K 4 Director 03 Nov 2021, 19:00
TARS Tarsus Pharmaceuticals, Inc. 12 Oct 2021 2 -$148K 4 Director 14 Oct 2021, 16:48
TARS Tarsus Pharmaceuticals, Inc. 08 Oct 2021 1 -$5.01K 4 Director 12 Oct 2021, 18:47
TARS Tarsus Pharmaceuticals, Inc. 01 Sep 2021 1 -$147K 4 Director 03 Sep 2021, 18:53
TARS Tarsus Pharmaceuticals, Inc. 11 Aug 2021 1 -$15.6K 4 Director 12 Aug 2021, 17:27
TARS Tarsus Pharmaceuticals, Inc. 06 Aug 2021 2 -$95.7K 4 Director 10 Aug 2021, 16:55
TARS Tarsus Pharmaceuticals, Inc. 05 Aug 2021 3 -$34.6K 4 Director 06 Aug 2021, 16:16
TARS Tarsus Pharmaceuticals, Inc. 15 Jun 2021 4 $0 4 Director 17 Jun 2021, 19:19